-
Something wrong with this record ?
Changes in sensorimotor network activation after botulinum toxin type A injections in patients with cervical dystonia: a functional MRI study
M. Nevrlý, P. Hluštík, P. Hok, P. Otruba, Z. Tüdös, P. Kaňovský,
Language English Country Germany
Document type Journal Article
Grant support
NV16-30210A
MZ0
CEP Register
Digital library NLK
Full text - Article
NLK
ProQuest Central
from 2001-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2000-01-01 to 1 year ago
Nursing & Allied Health Database (ProQuest)
from 2001-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 2001-01-01 to 1 year ago
Psychology Database (ProQuest)
from 2001-01-01 to 1 year ago
- MeSH
- Afferent Pathways diagnostic imaging drug effects MeSH
- Botulinum Toxins, Type A therapeutic use MeSH
- Adult MeSH
- Oxygen blood MeSH
- Middle Aged MeSH
- Humans MeSH
- Magnetic Resonance Imaging methods MeSH
- Statistics, Nonparametric MeSH
- Neuromuscular Agents therapeutic use MeSH
- Image Processing, Computer-Assisted MeSH
- Psychomotor Performance drug effects MeSH
- Aged MeSH
- Sensorimotor Cortex diagnostic imaging drug effects MeSH
- Torticollis * diagnostic imaging drug therapy physiopathology MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
Botulinum toxin type A (BoNT) is considered an effective therapeutic option in cervical dystonia (CD). The pathophysiology of CD and other focal dystonias has not yet been fully explained. Results from neurophysiological and imaging studies suggest a significant involvement of the basal ganglia and thalamus, and functional abnormalities in premotor and primary sensorimotor cortical areas are considered a crucial factor in the development of focal dystonias. Twelve BoNT-naïve patients with CD were examined with functional MRI during a skilled hand motor task; the examination was repeated 4 weeks after the first BoNT injection to the dystonic neck muscles. Twelve age- and gender-matched healthy controls were examined using the same functional MRI paradigm without BoNT injection. In BoNT-naïve patients with CD, BoNT treatment was associated with a significant increase of activation in finger movement-induced fMRI activation of several brain areas, especially in the bilateral primary and secondary somatosensory cortex, bilateral superior and inferior parietal lobule, bilateral SMA and premotor cortex, predominantly contralateral primary motor cortex, bilateral anterior cingulate cortex, ipsilateral thalamus, insula, putamen, and in the central part of cerebellum, close to the vermis. The results of the study support observations that the BoNT effect may have a correlate in the central nervous system level, and this effect may not be limited to cortical and subcortical representations of the treated muscles. The results show that abnormalities in sensorimotor activation extend beyond circuits controlling the affected body parts in CD even the first BoNT injection is associated with changes in sensorimotor activation. The differences in activation between patients with CD after treatment and healthy controls at baseline were no longer present.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012570
- 003
- CZ-PrNML
- 005
- 20190704103659.0
- 007
- ta
- 008
- 190405s2018 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00221-018-5322-3 $2 doi
- 035 __
- $a (PubMed)29971454
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Nevrlý, Martin $7 xx0237697 $u Department of Neurology, University Hospital and Faculty of Medicine and Dentistry of Palacký University, I. P. Pavlova 6, 775 20, Olomouc, Czech Republic. martin.nevrly@fnol.cz.
- 245 10
- $a Changes in sensorimotor network activation after botulinum toxin type A injections in patients with cervical dystonia: a functional MRI study / $c M. Nevrlý, P. Hluštík, P. Hok, P. Otruba, Z. Tüdös, P. Kaňovský,
- 520 9_
- $a Botulinum toxin type A (BoNT) is considered an effective therapeutic option in cervical dystonia (CD). The pathophysiology of CD and other focal dystonias has not yet been fully explained. Results from neurophysiological and imaging studies suggest a significant involvement of the basal ganglia and thalamus, and functional abnormalities in premotor and primary sensorimotor cortical areas are considered a crucial factor in the development of focal dystonias. Twelve BoNT-naïve patients with CD were examined with functional MRI during a skilled hand motor task; the examination was repeated 4 weeks after the first BoNT injection to the dystonic neck muscles. Twelve age- and gender-matched healthy controls were examined using the same functional MRI paradigm without BoNT injection. In BoNT-naïve patients with CD, BoNT treatment was associated with a significant increase of activation in finger movement-induced fMRI activation of several brain areas, especially in the bilateral primary and secondary somatosensory cortex, bilateral superior and inferior parietal lobule, bilateral SMA and premotor cortex, predominantly contralateral primary motor cortex, bilateral anterior cingulate cortex, ipsilateral thalamus, insula, putamen, and in the central part of cerebellum, close to the vermis. The results of the study support observations that the BoNT effect may have a correlate in the central nervous system level, and this effect may not be limited to cortical and subcortical representations of the treated muscles. The results show that abnormalities in sensorimotor activation extend beyond circuits controlling the affected body parts in CD even the first BoNT injection is associated with changes in sensorimotor activation. The differences in activation between patients with CD after treatment and healthy controls at baseline were no longer present.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a aferentní nervové dráhy $x diagnostické zobrazování $x účinky léků $7 D000344
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a botulotoxiny typu A $x terapeutické užití $7 D019274
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a počítačové zpracování obrazu $7 D007091
- 650 _2
- $a magnetická rezonanční tomografie $x metody $7 D008279
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a nervosvalové látky $x terapeutické užití $7 D009465
- 650 _2
- $a kyslík $x krev $7 D010100
- 650 _2
- $a psychomotorický výkon $x účinky léků $7 D011597
- 650 _2
- $a senzorimotorický kortex $x diagnostické zobrazování $x účinky léků $7 D066191
- 650 _2
- $a neparametrická statistika $7 D018709
- 650 12
- $a tortikolis $x diagnostické zobrazování $x farmakoterapie $x patofyziologie $7 D014103
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hluštík, Petr $u Department of Neurology, University Hospital and Faculty of Medicine and Dentistry of Palacký University, I. P. Pavlova 6, 775 20, Olomouc, Czech Republic. Department of Radiology, University Hospital and Faculty of Medicine and Dentistry of Palacký University, Olomouc, Czech Republic.
- 700 1_
- $a Hok, Pavel $u Department of Neurology, University Hospital and Faculty of Medicine and Dentistry of Palacký University, I. P. Pavlova 6, 775 20, Olomouc, Czech Republic.
- 700 1_
- $a Otruba, Pavel $u Department of Neurology, University Hospital and Faculty of Medicine and Dentistry of Palacký University, I. P. Pavlova 6, 775 20, Olomouc, Czech Republic.
- 700 1_
- $a Tüdös, Zbyněk $u Department of Radiology, University Hospital and Faculty of Medicine and Dentistry of Palacký University, Olomouc, Czech Republic.
- 700 1_
- $a Kaňovský, Petr $u Department of Neurology, University Hospital and Faculty of Medicine and Dentistry of Palacký University, I. P. Pavlova 6, 775 20, Olomouc, Czech Republic.
- 773 0_
- $w MED00009710 $t Experimental brain research $x 1432-1106 $g Roč. 236, č. 10 (2018), s. 2627-2637
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29971454 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190704103850 $b ABA008
- 999 __
- $a ok $b bmc $g 1391880 $s 1050875
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 236 $c 10 $d 2627-2637 $e 20180703 $i 1432-1106 $m Experimental Brain Research $n Exp Brain Res $x MED00009710
- GRA __
- $a NV16-30210A $p MZ0
- LZP __
- $a Pubmed-20190405